Aflac Incorporated (NYSE:AFL) is Security National Bank of Sioux City Iowa IA’s 6th Largest Position

Security National Bank of Sioux City Iowa IA lowered its stake in Aflac Incorporated (NYSE:AFL) by 0.5% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 33,724 shares of the financial services provider’s stock after selling 153 shares during the quarter. Aflac makes up 2.4% of Security National Bank of Sioux City Iowa IA’s portfolio, making the stock its 6th biggest position. Security National Bank of Sioux City Iowa IA’s holdings in Aflac were worth $3,488,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Barclays PLC increased its position in shares of Aflac by 10.1% during the third quarter. Barclays PLC now owns 1,391,127 shares of the financial services provider’s stock valued at $155,529,000 after acquiring an additional 127,911 shares in the last quarter. Miracle Mile Advisors LLC lifted its position in shares of Aflac by 21.3% during the 4th quarter. Miracle Mile Advisors LLC now owns 6,078 shares of the financial services provider’s stock valued at $629,000 after buying an additional 1,068 shares in the last quarter. SeaCrest Wealth Management LLC lifted its holdings in Aflac by 4.9% during the fourth quarter. SeaCrest Wealth Management LLC now owns 5,029 shares of the financial services provider’s stock valued at $520,000 after purchasing an additional 235 shares in the last quarter. Fifth Third Wealth Advisors LLC raised its position in shares of Aflac by 21.7% during the 4th quarter. Fifth Third Wealth Advisors LLC now owns 13,925 shares of the financial services provider’s stock valued at $1,440,000 after purchasing an additional 2,486 shares during the period. Finally, Assenagon Asset Management S.A. raised its holdings in Aflac by 670.9% during the fourth quarter. Assenagon Asset Management S.A. now owns 556,576 shares of the financial services provider’s stock valued at $57,572,000 after acquiring an additional 484,378 shares during the period. Institutional investors own 67.44% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have recently issued reports on the stock. Keefe, Bruyette & Woods lifted their price objective on shares of Aflac from $104.00 to $106.00 and gave the company a “market perform” rating in a research report on Wednesday, May 7th. StockNews.com lowered Aflac from a “hold” rating to a “sell” rating in a research note on Monday, May 5th. BMO Capital Markets assumed coverage on shares of Aflac in a research note on Thursday, January 23rd. They set a “market perform” rating and a $111.00 price target for the company. Barclays boosted their price objective on Aflac from $95.00 to $96.00 and gave the company an “underweight” rating in a report on Thursday, May 1st. Finally, UBS Group upped their target price on shares of Aflac from $109.00 to $114.00 and gave the stock a “neutral” rating in a research note on Wednesday, April 2nd. Three equities research analysts have rated the stock with a sell rating, ten have given a hold rating and two have issued a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $104.21.

Aflac Price Performance

Shares of AFL stock opened at $105.73 on Friday. The stock’s 50-day moving average is $106.99 and its 200 day moving average is $106.51. The company has a debt-to-equity ratio of 0.29, a current ratio of 0.10 and a quick ratio of 0.08. Aflac Incorporated has a 1-year low of $86.46 and a 1-year high of $115.50. The company has a market cap of $57.16 billion, a P/E ratio of 11.01, a PEG ratio of 3.24 and a beta of 0.84.

Aflac (NYSE:AFL) last announced its earnings results on Wednesday, April 30th. The financial services provider reported $1.66 earnings per share for the quarter, missing the consensus estimate of $1.67 by ($0.01). Aflac had a return on equity of 16.20% and a net margin of 28.76%. The business had revenue of $3.40 billion for the quarter, compared to analysts’ expectations of $4.53 billion. During the same quarter last year, the firm earned $1.66 earnings per share. The firm’s quarterly revenue was down 37.5% compared to the same quarter last year. Research analysts predict that Aflac Incorporated will post 6.88 earnings per share for the current fiscal year.

Aflac Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, June 2nd. Stockholders of record on Wednesday, May 21st will be issued a $0.58 dividend. This represents a $2.32 dividend on an annualized basis and a dividend yield of 2.19%. The ex-dividend date of this dividend is Wednesday, May 21st. Aflac’s dividend payout ratio is presently 36.25%.

Insiders Place Their Bets

In other Aflac news, Director Charles D. Lake II sold 29,802 shares of the company’s stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $107.29, for a total value of $3,197,456.58. Following the completion of the transaction, the director now owns 49,962 shares in the company, valued at approximately $5,360,422.98. This represents a 37.36% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Joseph L. Moskowitz sold 1,000 shares of the stock in a transaction that occurred on Thursday, May 8th. The stock was sold at an average price of $106.79, for a total value of $106,790.00. Following the transaction, the director now owns 26,096 shares in the company, valued at $2,786,791.84. This represents a 3.69% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 31,802 shares of company stock valued at $3,411,877. 0.90% of the stock is owned by insiders.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.